The withdrawal of rofecoxib

This publication has 37 references indexed in Scilit:

• Utilization of nonsteroidal anti-inflammatory drugs and antisecretory agents: a managed care claims analysis
  The American Journal of Medicine, 2004
• The effects of physician specialty and patient comorbidities on the use and discontinuation of coxibs
  Arthritis Care & Research, 2003
• Understanding the Divergent Data on Postmenopausal Hormone Therapy
  New England Journal of Medicine, 2003
• Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial
  JAMA, 2002
• Promotion of Prescription Drugs to Consumers
  New England Journal of Medicine, 2002
• The Coxibs, Selective Inhibitors of Cyclooxygenase-2
  New England Journal of Medicine, 2001
• Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid Arthritis
  New England Journal of Medicine, 2000
• Epidemiology Faces Its Limits
  Published by American Association for the Advancement of Science (AAAS) ,1995
• A historical perspective of elevated systolic vs diastolic blood pressure from an epidemiological and clinical trial viewpoint*1
  Journal of Clinical Epidemiology, 1989
• Blood Pressure and Risk of Coronary Heart Disease: The Framingham Study
  Diseases of the Chest, 1969